4.1 Article

The Subjective Effects of Psychedelics May Not Be Necessary for Their Enduring Therapeutic Effects

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Multidisciplinary Sciences

A non-hallucinogenic psychedelic analogue with therapeutic potential

Lindsay P. Cameron et al.

Summary: The study identifies key structural elements of the potential therapeutic pharmacophore of ibogaine and designs tabernanthalog, a safer, non-hallucinogenic analogue of ibogaine. Tabernanthalog is found to promote neural plasticity, reduce addiction-related behavior, and produce antidepressant effects in rodents. Through careful chemical design, it is possible to modify psychedelic compounds to produce safer, non-hallucinogenic variants with therapeutic potential.

NATURE (2021)

Article Chemistry, Medicinal

Transient Stimulation with Psychoplastogens Is Sufficient to Initiate Neuronal Growth

Calvin Ly et al.

Summary: Cortical neuron atrophy is a hallmark of depression, and psychoplastogens like ketamine and LSD have been shown to promote sustained growth of cortical neurons after short periods of stimulation. These psychoplastogens induce cortical neuron growth through distinct phases, with early TrkB activation and later sustained mTOR and AMPA receptor activation being crucial. It is suggested that rapidly excreted psychoplastogens may have unique advantages as neurotherapeutics compared to compounds like ketamine and LSD.

ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2021)

Article Chemistry, Medicinal

The Subjective Effects of Psychedelics Are Necessary for Their Enduring Therapeutic Effects

David B. Yaden et al.

Summary: The subjective effects of psychedelics are crucial for their lasting benefits, accounting for the majority of their therapeutic outcomes.

ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2021)

Article Neurosciences

Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects

Friederike Holze et al.

NEUROPSYCHOPHARMACOLOGY (2020)

Editorial Material Biochemistry & Molecular Biology

Psychedelic Psychiatry's Brave New World

David Nutt et al.

Article Psychology, Clinical

Psychedelic Microdosing: Prevalence and Subjective Effects

Lindsay P. Cameron et al.

JOURNAL OF PSYCHOACTIVE DRUGS (2020)

Editorial Material Clinical Neurology

Microdosing psychedelics: More questions than answers? An overview and suggestions for future research

Kim P. C. Kuypers et al.

JOURNAL OF PSYCHOPHARMACOLOGY (2019)

Review Biochemistry & Molecular Biology

Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine

Lee E. Dunlap et al.

ACS CHEMICAL NEUROSCIENCE (2018)

Article Cell Biology

Psychedelics Promote Structural and Functional Neural Plasticity

Calvin Ly et al.

CELL REPORTS (2018)

Article Pharmacology & Pharmacy

Psychedelics as Medicines: An Emerging New Paradigm

D. E. Nichols et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)

Article Multidisciplinary Sciences

NMDAR inhibition-independent antidepressant actions of ketamine metabolites

Panos Zanos et al.

NATURE (2016)

Article Clinical Neurology

Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study

Michael P. Bogenschutz et al.

JOURNAL OF PSYCHOPHARMACOLOGY (2015)

Article Substance Abuse

Therapeutic infusions of ketamine: Do the psychoactive effects matter?

E. Dakwar et al.

DRUG AND ALCOHOL DEPENDENCE (2014)

Article Clinical Neurology

Do the dissociative side effects of ketamine mediate its antidepressant effects?

David A. Luckenbaugh et al.

JOURNAL OF AFFECTIVE DISORDERS (2014)

Article Multidisciplinary Sciences

Psychometric Evaluation of the Altered States of Consciousness Rating Scale (OAV)

Erich Studerus et al.

PLOS ONE (2010)

Review Neurosciences

New approaches to antidepressant drug discovery: beyond monoamines

O Berton et al.

NATURE REVIEWS NEUROSCIENCE (2006)

Article Anesthesiology

Small-dose ketamine improves the postoperative state of depressed patients

A Kudoh et al.

ANESTHESIA AND ANALGESIA (2002)

Article Neurosciences

Antidepressant effects of ketamine in depressed patients

RM Berman et al.

BIOLOGICAL PSYCHIATRY (2000)